Drug interactions
Hydroxyurea + Lovotibeglogene autotemcel
Severity: Major
Hydroxyurea and Lovotibeglogene autotemcel: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Hydroxyurea suppresses the bone marrow and may reduce stem cell yield during mobilization and apheresis. It may also affect engraftment of gene-modified cells.
What this interaction means in plain words
Hydroxyurea and Lovotibeglogene autotemcel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
Myelosuppression reduces CD34+ cell collection and engraftment.
What to do
Stop hydroxyurea at least 2 months before mobilization and keep it off until apheresis is complete, then stop it 2 days before conditioning per labeling. Plan alternative disease control with the transplant team.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Hydroxyurea and Lovotibeglogene autotemcel, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Hydroxyurea
Frequently asked questions
Can I take Hydroxyurea with Lovotibeglogene autotemcel?
MediHelp rates the interaction as major. Hydroxyurea and Lovotibeglogene autotemcel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Hydroxyurea suppresses the bone marrow and may reduce stem cell yield during mobilization and apheresis. It may also affect engraftment of gene-modified cells.
How serious is the interaction between Hydroxyurea and Lovotibeglogene autotemcel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Stop hydroxyurea at least 2 months before mobilization and keep it off until apheresis is complete, then stop it 2 days before conditioning per labeling. Plan alternative disease control with the transplant team.
What other medicines interact with Hydroxyurea?
MediHelp also lists interactions of Hydroxyurea with, for example, Didanosine, Adenovirus types 4 and 7 live, Axicabtagene ciloleucel. The full list is on the Hydroxyurea page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
